These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19230021)

  • 1. Pharmacokinetic and pharmacodynamic evaluation of the suitability of using fluticasone and an acute rat lung inflammation model to differentiate lung versus systemic efficacy.
    Chiang PC; Hu Y; Thurston A; Sommers CD; Guzova JA; Kahn LE; Lai Y; Blom JD
    J Pharm Sci; 2009 Nov; 98(11):4354-64. PubMed ID: 19230021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations.
    Chiang PC; Hu Y; Blom JD; Thompson DC
    Nanoscale Res Lett; 2010 Apr; 5(6):1010-9. PubMed ID: 20672144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH; Brutsche IC; Munawar M; Langley SJ; Masterson CM; Daley-Yates PT; Brown R; Custovic A; Woodcock A
    Lancet; 2000 Aug; 356(9229):556-61. PubMed ID: 10950233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.
    Miller-Larsson A; Jansson P; Runström A; Brattsand R
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1455-61. PubMed ID: 11029361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose Predictions.
    Caniga M; Cabal A; Mehta K; Ross DS; Gil MA; Woodhouse JD; Eckman J; Naber JR; Callahan MK; Goncalves L; Hill SE; Mcleod RL; McIntosh F; Freke MC; Visser SA; Johnson N; Salmon M; Cicmil M
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):362-77. PubMed ID: 26859446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma.
    Belvisi MG; Bundschuh DS; Stoeck M; Wicks S; Underwood S; Battram CH; Haddad el-B; Webber SE; Foster ML
    J Pharmacol Exp Ther; 2005 Aug; 314(2):568-74. PubMed ID: 15878996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids.
    Kelly HW
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):326-34; quiz 334-5, 404. PubMed ID: 14582810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
    Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Gan WQ; Rousseau R;
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1207-14. PubMed ID: 18310480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of high-dose inhaled corticosteroids.
    Brutsche-Carlen M; Carlen-Brutsche I; Woodcock A
    Chest; 2000 May; 117(5):1526. PubMed ID: 10807856
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic and pulmonary effects of fluticasone administered through a metered-dose inhaler in rats.
    Sorkness RL; Remus JL; Rosenthal LA
    J Allergy Clin Immunol; 2004 Nov; 114(5):1027-32. PubMed ID: 15536405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles.
    Popov A; Schopf L; Bourassa J; Chen H
    Int J Pharm; 2016 Apr; 502(1-2):188-97. PubMed ID: 26902722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.
    Selg E; Ewing P; Acevedo F; Sjöberg CO; Ryrfeldt A; Gerde P
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):181-9. PubMed ID: 23094685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole comedication increases systemic levels of inhaled fluticasone in lung transplant recipients.
    Naef R; Schmid C; Hofer M; Minder S; Speich R; Boehler A
    Respiration; 2007; 74(4):418-22. PubMed ID: 17003527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel in vivo receptor occupancy methodology for the glucocorticoid receptor: toward an improved understanding of lung pharmacokinetic/pharmacodynamic relationships.
    Boger E; Ewing P; Eriksson UG; Fihn BM; Chappell M; Evans N; Fridén M
    J Pharmacol Exp Ther; 2015 May; 353(2):279-87. PubMed ID: 25680710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate.
    Tayab ZR; Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ; Hochhaus G
    Br J Clin Pharmacol; 2007 Nov; 64(5):698-705. PubMed ID: 17509041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of fluticasone propionate.
    Shaw RJ
    Respir Med; 1994 Aug; 88 Suppl A():5-8. PubMed ID: 7972993
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
    Lawrence M; Wolfe J; Webb DR; Chervinsky P; Kellerman D; Schaumberg JP; Shah T
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.